FDA Adverse Event Malfunction Summary report: N

COLLAMER ULTRAVIOLET-ABSORBING POSTERIOR CHAMBER THREE PEIECE FOLDABLE INTRAOCUL

MDR report key: 1031390 · Received April 18, 2008

Report

Report Number
2023826-2008-00530
Event Type
Malfunction
Date Received
April 18, 2008
Date of Event
March 19, 2008
Report Date
March 20, 2008
Manufacturer
STAAR SURGICAL COMPANY
Product Code
HQL
PMA / PMN Number
P990013
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

EVAL RESULTS - VISUAL INSPECTION OF THE RETURNED PRODUCT SHOWED THAT A HAPTIC AND PART OF THE OPTIC WAS TORN OFF AND MISSING AND THERE WAS A REDDISH RESIDUE ON THE LENS. CONCLUSION: AN INVESTIGATION WAS OPENED TO EVALUATE A COMPLAINT TREND ASSOCIATED WITH LENS TEARS THAT WAS ORIGINALLY IDENTIFIED IN JUNE 2005. THE DAMAGE TO THE LENS, AS OBSERVED AND PHOTOGRAPHED UPON THE RETURN OF THE LENS TO STAAR, CANNOT BE DEFINITIVELY AND EXCLUSIVELY CORRELATED TO A SPECIFIC ROOT CAUSE. POSSIBLE ROOT CAUSES FOR LENS TEARS INCLUDE BOTH DELIVERY SYSTEM ISSUES AND POSSIBLE HANDLING ERRORS BY THE CUSTOMER. TO ADDRESS DELIVERY SYSTEM ISSUES, ALL STAGES IN THE MANUFACTURING OF THE INJECTORS AND CARTRIDGES WERE REVIEWED AND REVISED AS OPPORTUNITIES FOR IMPROVEMENT WERE REVEALED. TO ADDRESS HANDLING ERRORS, ALL INJECTOR/CARTRIDGE DIRECTIONS FOR USE (DFU) HAVE BEEN MODIFIED TO ADD FURTHER CLARIFICATIONS TO INSTRUCT THE USERS IN THE PROPER DELIVERY TECHNIQUES THAT ARE EFFECTIVE, AND MINIMIZE THE POTENTIAL FOR DAMAGING THE LENS.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE SURGEON ATTEMPTED TO INSERT A CQ2015 THREE PIECE COLLAMER LENS AND THE LENS WAS TORE WHILE ADVANCING IN INJECTOR. NO PATIENT CONTRACT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 COLLAMER ULTRAVIOLET-ABSORBING POSTERIOR CHAMBER THREE PEIECE FOLDABLE INTRAOCUL INTRAOCULAR LENS HQL STAAR SURGICAL COMPANY CQ2015 NA

Patients

Seq Age Sex Outcome Treatment
1 80 YR STAARVISC II| CARTRIDGE MODEL CQ CARTRDIGE-FP| INJECTOR MODEL MSI-PM